Breaking

John Maraganore, a well-known figure in the biotech industry, recently discussed his involvement in the innovative RNAi startup, City Therapeutics, on the latest episode of STAT's biotech podcast, "The Readout LOUD." Maraganore shared insights...

A recent analysis revealed that nearly 60% of experts who reviewed manuscripts for four major medical journals received payments from the industry. The study, conducted over a three-year period, found that these reviewers and...

Bill Nye, best known as the Science Guy, has shifted his focus to bring attention to ataxia, a neurological disease that has impacted his family for generations. He has teamed up with the National...

Late Tuesday night, Carequality revealed new details about the ongoing dispute between electronic health records giant Epic Systems and health data startup Particle Health. The conflict has now escalated to the point of an...

Bluebird Bio's gene therapy, known as Skysona, has been linked to the development of blood cancers in seven out of 67 children who received the treatment for a severe neurological disorder in clinical trials....

Good day to all our readers, we hope you are having a productive week so far. As we look forward to the weekend, let's stay focused and keep pushing forward. Today, we suggest enjoying...

Ultragenyx's founder and CEO, Kakkis, is at the forefront of developing another treatment for an ultra-rare disease called Barth syndrome. This genetic disorder affects around 200 boys worldwide and is caused by a mutation...

ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in two years that the company has taken such steps. Despite...

On Tuesday, Mark Cuban, the billionaire business mogul, seemed to have insider information about Vice President Harris' presidential campaign's proposal to crack down on middlemen in the pharmaceutical industry. The campaign announcement coincided with...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.Why do bad menstrual cramps happen to good people? A study answering that question would get the Gaffney Prize...

Scholar Rock, a biotech company, announced on Monday that their new drug has shown promising results in a late-stage study for spinal muscular atrophy. The drug, called apitegromab, was tested in a year-long Phase...

Georgina Peacock shared a poignant memory of a night during her pediatric medical training when she admitted 20 babies struggling to breathe due to Respiratory Syncytial Virus (RSV). Since then, efforts have been relentless...